Charles Schwab
BDSI

Charles Schwab’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Charles Schwab’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-715,184
Closed -$2.22M – 3690
2021
Q4 		$2.22M Buy
715,184
+60,887
+9% +$205K ﹤0.01% 2674
2021
Q3 		$2.36M Buy
654,297
+1,412
+0.2% +$5.33K ﹤0.01% 2661
2021
Q2 		$2.34M Sell
652,885
-47,817
-7% -$169K ﹤0.01% 2662
2021
Q1 		$2.74M Sell
700,702
-3,987
-0.6% -$16.5K ﹤0.01% 2562
2020
Q4 		$2.96M Buy
704,689
+21,848
+3% +$84.2K ﹤0.01% 2466
2020
Q3 		$2.55M Sell
682,841
-5,157
-0.7% -$21.9K ﹤0.01% 2411
2020
Q2 		$3M Buy
687,998
+10,102
+1% +$45.4K ﹤0.01% 2274
2020
Q1 		$2.57M Buy
677,896
+164,585
+32% +$809K ﹤0.01% 2168
2019
Q4 		$3.25M Sell
513,311
-6,206
-1% -$36.5K ﹤0.01% 2236
2019
Q3 		$2.19M Buy
519,517
+333,108
+179% +$1.42M ﹤0.01% 2347
2019
Q2 		$867K Buy
186,409
+169,757
+1,019% +$790K ﹤0.01% 2620
2019
Q1 		$89K Hold
16,652
– – ﹤0.01% 3097
2018
Q4 		$62K Hold
16,652
– – ﹤0.01% 3120
2018
Q3 		$47K Buy
+16,652
New +$46.7K ﹤0.01% 3129
2016
Q4 		– Sell
-14,119
Closed -$39K – 3113
2016
Q3 		$39K Hold
14,119
– – ﹤0.01% 3028
2016
Q2 		$34K Sell
14,119
-79,500
-85% -$219K ﹤0.01% 3086
2016
Q1 		$303K Hold
93,619
– – ﹤0.01% 2773
2015
Q4 		$449K Hold
93,619
– – ﹤0.01% 2692
2015
Q3 		$521K Buy
93,619
+19,500
+26% +$144K ﹤0.01% 2608
2015
Q2 		$590K Hold
74,119
– – ﹤0.01% 2619
2015
Q1 		$779K Hold
74,119
– – ﹤0.01% 2468
2014
Q4 		$891K Hold
74,119
– – ﹤0.01% 2408
2014
Q3 		$1.27M Buy
74,119
+14,119
+24% +$205K ﹤0.01% 2194
2014
Q2 		$725K Buy
60,000
+10,500
+21% +$99.5K ﹤0.01% 2482
2014
Q1 		$418K Hold
49,500
– – ﹤0.01% 2663
2013
Q4 		$292K Hold
49,500
– – ﹤0.01% 2822
2013
Q3 		$289K Hold
49,500
– – ﹤0.01% 2771
2013
Q2 		$206K Buy
+49,500
New +$232K ﹤0.01% 2887

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Charles Schwab's BDSI Position: Q1 2022 in Review

Charles Schwab sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 715,184 shares — an estimated $2.22M sold.

Charles Schwab first reported a position in BDSI in Q2 2013 and held it in 28 quarters. The position peaked at $3.25M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Charles Schwab reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Charles Schwab sold 715,184 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $2.22M.
  • Charles Schwab first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 28 quarters.
  • Charles Schwab's BioDelivery Sciences International, Inc. position peaked at $3.25M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.